EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endothelial dysfunction: molecular mechanisms and clinical implications

Xia Wang, Ben He

MedComm · 2024-08 · 5 (8)

DOI: 10.1002/mco2.651 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 22.07.2024. Verfasst von Xia Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China. Die Arbeit wurde bisher 274-mal zitiert (Crossref) und nennt 287 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) and its complications are a leading cause of death worldwide. Endothelial dysfunction plays a crucial role in the initiation and progression of CVD, serving as a pivotal factor in the pathogenesis of cardiovascular, metabolic, and other related diseases. The regulation of endothelial dysfunction is influenced by various risk factors and intricate signaling pathways, which vary depending on the specific disease context. Despite numerous research efforts aimed at elucidating the mechanisms underlying endothelial dysfunction, the precise molecular pathways involved remain incompletely understood. This review elucidates recent research findings on the pathophysiological mechanisms involved in endothelial dysfunction, including nitric oxide availability, oxidative stress, and inflammation‐mediated pathways. We also discuss the impact of endothelial dysfunction on various pathological conditions, including atherosclerosis, heart failure, diabetes, hypertension, chronic kidney disease, and neurodegenerative diseases. Furthermore, we summarize the traditional and novel potential biomarkers of endothelial dysfunction as well as pharmacological and nonpharmacological therapeutic strategies for endothelial protection and treatment for CVD and related complications. Consequently, this review is to improve understanding of emerging biomarkers and therapeutic approaches aimed at reducing the risk of developing CVD and associated complications, as well as mitigating endothelial dysfunction.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseaseendothelial dysfunctioninflammationnitric oxideoxidative stress

Autor:innen und Institutionen

  • Department of Cardiology Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., & He, B. (2024). Endothelial dysfunction: molecular mechanisms and clinical implications. MedComm, 5(8). https://doi.org/10.1002/mco2.651

Vancouver

Wang X, He B. Endothelial dysfunction: molecular mechanisms and clinical implications. MedComm. 2024;5(8). doi:10.1002/mco2.651

BibTeX
@article{Wang2024,
  author = {Wang, Xia and He, Ben},
  title = {Endothelial dysfunction: molecular mechanisms and clinical implications},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {8},
  doi = {10.1002/mco2.651}
}
Kostenlos starten →